CD274 and non-small cell lung carcinoma: Fourthly, because in daily practice more biopsy samples than resection specimens from NSCLC, including advanced-stage cases, are used for diagnosis and biomarker assessment for optimal patient selection to personalize treatment strategies and track therapeutic efficacy, in future studies, tissue sampling should be carried out on biopsies to measure PD-L1 expression in ex vivo analysis.